Insider · CIK 0001257241

Durus Capital Management NA LLC

CIK 0001257241 Name as filed on the most recent filing

Filed as Durus Capital Management NA LLC (50)

1,473 transaction lines · from 50 filings · filed 2003-07-31 to 2003-07-31 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-28 05:24 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

0 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-28 05:24 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2003-02-06 P, Open-market purchase Aksys LtdAKSY 66,160, acquired Open Form 4 filing 0001005477-03-002886
2003-02-06 P, Open-market purchase Esperion Therapeutics Inc/MIESPR 3 lines 281,702, acquired Open Form 4 filing 0001005477-03-002848
2003-02-05 P, Open-market purchase Aksys LtdAKSY 310,558, acquired Open Form 4 filing 0001005477-03-002886
2003-02-05 P, Open-market purchase Esperion Therapeutics Inc/MIESPR 52,154, acquired Open Form 4 filing 0001005477-03-002848
2003-02-04 P, Open-market purchase Aksys LtdAKSY 254,167, acquired Open Form 4 filing 0001005477-03-002886
2003-02-04 P, Open-market purchase Esperion Therapeutics Inc/MIESPR 181,645, acquired Open Form 4 filing 0001005477-03-002848
2003-02-03 P, Open-market purchase Aksys LtdAKSY 234,367, acquired Open Form 4 filing 0001005477-03-002886
2003-02-03 P, Open-market purchase Esperion Therapeutics Inc/MIESPR 177,187, acquired Open Form 4 filing 0001005477-03-002848
2003-01-31 P, Open-market purchase Esperion Therapeutics Inc/MIESPR 2 lines 335,557, acquired Open Form 4 filing 0001005477-03-002847
2003-01-31 P, Open-market purchase Aksys LtdAKSY 3 lines 485,092, acquired Open Form 4 filing 0001005477-03-002886
2003-01-31 P, Open-market purchase Esperion Therapeutics Inc/MIESPR 63,732, acquired Open Form 4 filing 0001005477-03-002848
2003-01-30 P, Open-market purchase Esperion Therapeutics Inc/MIESPR 185,334, acquired Open Form 4 filing 0001005477-03-002847
2003-01-30 P, Open-market purchase Aksys LtdAKSY 233,141, acquired Open Form 4 filing 0001005477-03-002886
2003-01-29 P, Open-market purchase Esperion Therapeutics Inc/MIESPR 52,047, acquired Open Form 4 filing 0001005477-03-002847
2003-01-29 P, Open-market purchase Aksys LtdAKSY 140,533, acquired Open Form 4 filing 0001005477-03-002886
2003-01-28 P, Open-market purchase Esperion Therapeutics Inc/MIESPR 90,074, acquired Open Form 4 filing 0001005477-03-002847
2003-01-28 P, Open-market purchase Aksys LtdAKSY 134,768, acquired Open Form 4 filing 0001005477-03-002886
2003-01-27 P, Open-market purchase Esperion Therapeutics Inc/MIESPR 2 lines 135,970, acquired Open Form 4 filing 0001005477-03-002847
2003-01-27 P, Open-market purchase Aksys LtdAKSY 145,476, acquired Open Form 4 filing 0001005477-03-002886
2003-01-24 P, Open-market purchase Esperion Therapeutics Inc/MIESPR 2 lines 431,659, acquired Open Form 4 filing 0001005477-03-002847
2003-01-24 P, Open-market purchase Aksys LtdAKSY 2 lines 491,655, acquired Open Form 4 filing 0001005477-03-002886
2003-01-23 P, Open-market purchase Esperion Therapeutics Inc/MIESPR 2 lines 348,054, acquired Open Form 4 filing 0001005477-03-002847
2003-01-23 P, Open-market purchase Aksys LtdAKSY 2 lines 257,382, acquired Open Form 4 filing 0001005477-03-002886
2003-01-22 P, Open-market purchase Esperion Therapeutics Inc/MIESPR 138,609, acquired Open Form 4 filing 0001005477-03-002847
2003-01-22 P, Open-market purchase Aksys LtdAKSY 227,910, acquired Open Form 4 filing 0001005477-03-002886
2003-01-21 P, Open-market purchase Esperion Therapeutics Inc/MIESPR 252,551, acquired Open Form 4 filing 0001005477-03-002847
2003-01-21 P, Open-market purchase Aksys LtdAKSY 242,859, acquired Open Form 4 filing 0001005477-03-002886
2003-01-17 P, Open-market purchase Esperion Therapeutics Inc/MIESPR 100,714, acquired Open Form 4 filing 0001005477-03-002847
2003-01-17 P, Open-market purchase Aksys LtdAKSY 75,593, acquired Open Form 4 filing 0001005477-03-002886
2003-01-16 P, Open-market purchase Esperion Therapeutics Inc/MIESPR 147,259, acquired Open Form 4 filing 0001005477-03-002847
2003-01-16 P, Open-market purchase Aksys LtdAKSY 90,069, acquired Open Form 4 filing 0001005477-03-002886
2003-01-15 P, Open-market purchase Esperion Therapeutics Inc/MIESPR 10,268, acquired Open Form 4 filing 0001005477-03-002847
2003-01-15 P, Open-market purchase Aksys LtdAKSY 88,501, acquired Open Form 4 filing 0001005477-03-002886
2003-01-14 P, Open-market purchase Esperion Therapeutics Inc/MIESPR 216,082, acquired Open Form 4 filing 0001005477-03-002847
2003-01-14 P, Open-market purchase Aksys LtdAKSY 170,071, acquired Open Form 4 filing 0001005477-03-002886
2003-01-13 P, Open-market purchase Esperion Therapeutics Inc/MIESPR 2 lines 139,370, acquired Open Form 4 filing 0001005477-03-002847
2003-01-13 P, Open-market purchase Aksys LtdAKSY 2 lines 134,756, acquired Open Form 4 filing 0001005477-03-002886
2003-01-10 P, Open-market purchase Esperion Therapeutics Inc/MIESPR 177,830, acquired Open Form 4 filing 0001005477-03-002847

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
P, Open-market purchase
Open-market purchase

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

No transaction line is stored for this entity, so there is nothing to break down by code. The catalog holds its filings; what it does not hold is a single reportable line from them, which is a fact about the parse and about these filings, not about the entity.

How to cite this page

ebomi catalog. DURUS CAPITAL MANAGEMENT NA LLC, insider transactions. Retrieved 2026-08-28 from https://ebomi.com/insider/0001257241

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.